421 related articles for article (PubMed ID: 25594891)
1. Curcumin-based anti-prostate cancer agents.
Chen QH
Anticancer Agents Med Chem; 2015; 15(2):138-56. PubMed ID: 25594891
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents.
Zhang X; Wang R; Perez GR; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2016 Oct; 24(19):4692-4700. PubMed ID: 27543391
[TBL] [Abstract][Full Text] [Related]
3. Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers.
Mbese Z; Khwaza V; Aderibigbe BA
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801262
[TBL] [Abstract][Full Text] [Related]
4. Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents.
Wang R; Chen C; Zhang X; Zhang C; Zhong Q; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
J Med Chem; 2015 Jun; 58(11):4713-26. PubMed ID: 25961334
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo.
Dorai T; Cao YC; Dorai B; Buttyan R; Katz AE
Prostate; 2001 Jun; 47(4):293-303. PubMed ID: 11398177
[TBL] [Abstract][Full Text] [Related]
6. Dehydrozingerone, a Curcumin Analog, as a Potential Anti-Prostate Cancer Inhibitor In Vitro and In Vivo.
Mapoung S; Suzuki S; Fuji S; Naiki-Ito A; Kato H; Yodkeeree S; Sakorn N; Ovatlarnporn C; Takahashi S; Limtrakul Dejkriengkraikul P
Molecules; 2020 Jun; 25(12):. PubMed ID: 32545675
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.
Wang R; Zhang X; Chen C; Chen G; Zhong Q; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2016 Mar; 110():164-80. PubMed ID: 26827161
[TBL] [Abstract][Full Text] [Related]
8. Novel anti-prostate cancer curcumin analogues that enhance androgen receptor degradation activity.
Shi Q; Shih CC; Lee KH
Anticancer Agents Med Chem; 2009 Oct; 9(8):904-12. PubMed ID: 19663790
[TBL] [Abstract][Full Text] [Related]
9. Potent Anti-Cancer Properties of Phthalimide-Based Curcumin Derivatives on Prostate Tumor Cells.
Belluti S; Orteca G; Semeghini V; Rigillo G; Parenti F; Ferrari E; Imbriano C
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577600
[TBL] [Abstract][Full Text] [Related]
10. Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs.
Sarkar FH; Li Y; Wang Z; Padhye S
Curr Pharm Des; 2010 Jun; 16(16):1801-12. PubMed ID: 20345353
[TBL] [Abstract][Full Text] [Related]
11. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin.
Shukla M; Jaiswal S; Sharma A; Srivastava PK; Arya A; Dwivedi AK; Lal J
Drug Dev Ind Pharm; 2017 May; 43(5):847-861. PubMed ID: 27648633
[TBL] [Abstract][Full Text] [Related]
12. Antitumor agents 247. New 4-ethoxycarbonylethyl curcumin analogs as potential antiandrogenic agents.
Lin L; Shi Q; Su CY; Shih CC; Lee KH
Bioorg Med Chem; 2006 Apr; 14(8):2527-34. PubMed ID: 16427289
[TBL] [Abstract][Full Text] [Related]
13. Poly(β-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells.
Yallapu MM; Jaggi M; Chauhan SC
Macromol Biosci; 2010 Oct; 10(10):1141-51. PubMed ID: 20572274
[TBL] [Abstract][Full Text] [Related]
14. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles.
Adahoun MA; Al-Akhras MH; Jaafar MS; Bououdina M
Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):98-107. PubMed ID: 26747522
[TBL] [Abstract][Full Text] [Related]
15. Curcumin: a boon to colonic diseases.
Sareen R; Jain N; Pandit V
Curr Drug Targets; 2013 Sep; 14(10):1210-8. PubMed ID: 23768171
[TBL] [Abstract][Full Text] [Related]
16. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer.
Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
J Control Release; 2015 Jul; 209():110-9. PubMed ID: 25912409
[TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR and Molecular Docking Studies on Design Anti-Prostate Cancer Curcumin Analogues.
Meng X; Cui L; Song F; Luan M; Ji J; Si H; Duan Y; Zhai H
Curr Comput Aided Drug Des; 2020; 16(3):245-256. PubMed ID: 30370853
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment.
Jordan BC; Mock CD; Thilagavathi R; Selvam C
Life Sci; 2016 May; 152():135-44. PubMed ID: 27018446
[TBL] [Abstract][Full Text] [Related]
19. Improving the anticancer activity of curcumin using nanocurcumin dispersion in water.
Basniwal RK; Khosla R; Jain N
Nutr Cancer; 2014; 66(6):1015-22. PubMed ID: 25068616
[TBL] [Abstract][Full Text] [Related]
20. A Review of Curcumin and Its Derivatives as Anticancer Agents.
Tomeh MA; Hadianamrei R; Zhao X
Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30818786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]